Surface-Active Agents: Clinical Trials

5 trials of Surface-Active Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 22Completed 2

Follow Surface-Active Agents: new trials by email Literature Review of Surface-Active Agents trials Research Report on Surface-Active Agents

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
London's Exogenous Surfactant Study for COVID19
Bovine Lipid Extract Surfactant - ARDS, Human, COVID-19
Phase 1 / Phase 2CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's202020-11-232021-11-11
Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
Surfactants, Saline Solution - Skin and Connective Tissue Diseases
Phase 1CompletedProf. Dr. Dr. Ursula Mirastschijski242016-12-082017-09-07
Aerosolized Surfactant in Neonatal RDS
Surfactant - Respiratory Distress Syndrome, Newborn
Phase 1 / Phase 2CompletedSood, Beena G., MD, MS1592014-12-012021-08-25
Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.
Curcumin, LED, Surfactant - Dentist-Patient Relations
Phase 1CompletedUniversity of Sao Paulo242014-01-012015-01-13
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
synthetic surfactant (CHF5633) - Respiratory Distress Syndrome in Premature Infants
Phase 1CompletedChiesi Farmaceutici S.p.A.402012-10-012020-07-31

Conditions studied

Respiratory Distress Syndrome (2)  ·  COVID-19 (1)  ·  Respiratory Distress Syndrome In Premature Infants (1)  ·  Respiratory Distress Syndrome, Newborn (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Chiesi Farmaceutici S.p.A. (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Prof. Dr. Dr. Ursula Mirastschijski (1)  ·  Sood, Beena G., MD, MS (1)  ·  University of Sao Paulo (1)

Countries

Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Beena G. Sood, MD, MS (1)  ·  Christian Speer, MD (1)  ·  Jim Lewis, MD (1)  ·  Ursula Mirastschijski, Prof. Dr. (1)

Results publications

PMID 24703280, PMID 28465315, PMID 33338661

NIH funding

2015 (1)